Table 5.
Cox proportional hazards model for time to all-cause allograft failure in discordant diabetic vs. non-diabetic recipient pairs
Univariate Analysis | Multivariable Analysis* | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
HR | SE | z | p-value | 95% CI | HR | SE | z | p-value | 95% CI | |
Non-Diabetic Donor | ||||||||||
Diabetic Recipient | 1.494 | 0.030 | 19.73 | < 0.001 | 1.436-1.555 | 1.445 | 0.041 | 13.07 | < 0.001 | 1.367-1.527 |
Non-Diabetic Recipient | REF | REF | ||||||||
Diabetic Donor | ||||||||||
Diabetic Recipient | 1.349 | 0.099 | 4.06 | < 0.001 | 1.168-1.558 | 1.269 | 0.120 | 2.52 | 0.012 | 1.054-1.528 |
Non-Diabetic Recipient | REF | REF | ||||||||
Recipient Characteristics | ||||||||||
Age > 40 | 1.033 | 0.039 | 0.86 | 0.390 | 0.959-1.113 | 1.019 | 0.051 | 0.37 | 0.712 | 0.923-1.125 |
Male | 1.092 | 0.032 | 3.02 | 0.003 | 1.031-1.156 | 1.061 | 0.042 | 1.50 | 0.134 | 0.982-1.146 |
African American Race | 1.197 | 0.041 | 5.29 | < 0.001 | 1.120-1.280 | 1.250 | 0.056 | 4.96 | < 0.001 | 1.145-1.366 |
Pre-Transplant Dialysis** | 1.054 | 0.006 | 9.45 | < 0.001 | 1.042-1.065 | |||||
Time on Waitlist (days) | 1.000 | 0.000 | 3.07 | 0.002 | 1.000-1.000 | |||||
Repeat Renal Transplant | 1.180 | 0.059 | 3.30 | 0.001 | 1.069-1.301 | |||||
HCV+ | 0.941 | 0.281 | −0.20 | 0.838 | 0.524-1.690 | 1.114 | 0.099 | 1.22 | 0.222 | 0.936-1.326 |
Max PRA ≥30 | 1.165 | 0.046 | 3.90 | < 0.001 | 1.079-1.258 | 1.226 | 0.066 | 3.80 | < 0.001 | 1.104-1.361 |
≥ 1 HLA Mismatch | 1.139 | 0.073 | 2.02 | 0.043 | 1.004-1.292 | |||||
Obese (BMI 7 gt;=30) | 1.127 | 0.035 | 3.83 | < 0.001 | 1.060-1.198 | |||||
Cold Ischemia Time | 1.006 | 0.002 | 2.56 | 0.010 | 1.001-1.010 | |||||
Delayed Graft Function | 1.770 | 0.063 | 16.00 | < 0.001 | 1.650-1.898 | |||||
Acute Rejection at 1 Year | 1.782 | 0.089 | 11.59 | < 0.001 | 1.616-1.965 | |||||
No Induction Immunosuppression |
0.987 | 0.036 | −0.37 | 0.715 | 0.919-1.060 | 1.083 | 0.054 | 1.61 | 0.108 | 0.983-1.193 |
Tacrolimus and the interaction term between tacrolimus and time were also included in the multivariable model
Included as an interaction term along with duration of dialysis or diabetes, as appropriate